Discovery Matters
111 episodes - English - Latest episode: 15 days ago - ★★★★★ - 19 ratingsA collection of stories and insights on matters of discovery that advance life sciences. Brought to you by the curious people at Cytiva.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
87. Cephalopods: From camouflage to communication
April 11, 2024 08:00 - 29 minutes - 66.9 MBLet's explore the remarkable colour-changing abilities of cephalopods. Joined by Dan Wilson from the Costas Research Institute at Northeastern University, the team dive into the fascinating research behind the development of paints that respond to environmental stimuli, such as sunlight. They also discuss titanium dioxide and how it acts as a facilitator of the colour-changing process. Professor Alon Gorodetsky, Associate Professor of Chemical and Biomolecular Engineering at the University o...
86. Synthetic biology
March 28, 2024 09:30 - 29 minutes - 67.9 MBIn this episode of Discovery Matters, hosts Dodi and Conor explore how synthetic biology can lead to transformative breakthroughs when it comes to dealing with global health problems. Through their conversation with Justin Vigar, a PhD student in Dr. Keith Pardee's lab at the University of Toronto in Canada, we learn how his team's paper-based diagnostic tool has the potential to provide faster, more cost-efficient, and accessible diagnostics for underserved locations. This is complemented b...
85. Drugging the undruggable
March 14, 2024 09:30 - 26 minutes - 60.4 MBTune in to Discovery Matters to see how we can drug the undruggable. Dodi and Conor talk to Mark Bray, a second year PhD student in the Bowman Lab at the University of Pennsylvania, about the concept of “drugging the undruggable” for drug discovery and development. They discuss advances in medical research which has enabled us to drug molecular targets that were previously inaccessible, and the strategies that are used to devise and find effective drugs. Vicky Richon, CEO at Entact Bio, eluc...
84. Unraveling biotech's AI transformation
February 23, 2024 11:57 - 30 minutes - 69.6 MBExplore the potential of artificial intelligence (AI) and machine learning to revolutionize biomedical research and make personalized healthcare a reality. Tune in to Discovery Matters to see how AI and machine learning will be the future of biomedical research. Featuring interviews with Professor Kourosh Saeb-Parsy and Dr Namshik Han — leaders in the AI and biotech space — this episode delves into the significance of advanced technology for unlocking discoveries in transplantation, underst...
83. Antibody drug conjugates
January 19, 2024 17:00 - 29 minutes - 66.6 MBLet’s explore the world of antibody drug conjugates (ADCs) and their potential for improving human health. Our two guests—Principal Investigator Sasha Ebrahimi from GSK and oncologist Dr. Paolo Tarantino—discuss the development and advantages of ADCs, and how they can be used to personalize treatments for cancer and other illnesses. Sasha explains how ADCs combine the targeting capabilities of antibodies with the cytotoxic effects of drugs, while Dr. Tarantino delves into his research with b...
82. Best of 2023
January 10, 2024 11:28 - 17 minutes - 39.6 MBDiscovery Matters is back with our best episodes and insights from the past year. Dodi and Conor re-explore some cutting-edge ideas and technologies pushing the frontiers of science and medicine forward. We look back on some of our favorite episodes including therapies such as psychedelic drugs, the sentience of brain cells, and the potential of marine microbes to fight cancer. They explore the potential of DNA to create medicine, the use of organoids in drug testing, and the use of cryopres...
80. Different strokes from different folks
January 10, 2024 11:26 - 24 minutes - 22.7 MBJoin Conor and Dodi in the latest episode of Discovery Matters, as they explore the wonders of ground-breaking scientific discoveries from multidisciplinary collaboration. MIT's Professor Pete Dedon expresses how multidisciplinary approaches and unique combinations of experiences can help to produce unexpected results. Professor James Evans of the University of Chicago then brings in the concept of surprise and hypergraphs to uncover the connections between different fields of knowledge. Wit...
79. Patient-derived organoids (part 2): Organic electronic materials
January 10, 2024 11:25 - 35 minutes - 81.3 MBLet’s explore the world of organoids and their potential to revolutionize disease treatment. Joined by Matthias Zilbauer and Roisin Owens, we look at the interplay of the gut-brain axis with organic electronic materials. Dive into the advances in organoid and microbial models used to develop treatments for illnesses such as Irritable Bowel Syndrome (IBS), Crohn’s Disease, and Ulcerative Colitis. Join Dodi and Conor to discover how bioengineering could change our understanding of health and d...
78. Lipid nanoparticles: a special delivery service
January 10, 2024 11:25 - 26 minutes - 23.9 MBIn this episode of Discovery Matters, we discuss the exciting potential of lipid nanoparticles (LNPs) to deliver genetic material and therapeutics to target cells and tissues. We are joined by Lloyd Jeffs, Senior Director of Biopharma Services at Precision NanoSystems, and Prof Dan Peer, Director of the Laboratory of Precision Nanomedicine at Tel Aviv University. Dan shares how his team has developed siRNA LNPs to deliver treatment more efficiently for ovarian cancer patients. From Dan's uni...
81. Access in developing nations
December 15, 2023 09:35 - 38 minutes - 87.7 MBChallenges of improving access to healthcare in developing countries - it's a conversation we need to have. With the help of Dr Jerome Kim, Director General of the International Vaccine Institute, we discuss vaccination and immunization programs as a key aspect of public health and global development – especially in developing nations, where access to life-saving medicines is often limited or non-existent. Karen Heichman, Deputy Director of Diagnostics, Bill and Melinda Gates Foundation, tak...
77. Combination therapies and serendipity
August 24, 2023 08:09 - 22 minutes - 20.4 MBThrough a discussion of combination therapies, Dodi and Conor delve into the mysterious power of the human microbiome, and antimicrobial resistance. With evidence of the microbiome being a key factor in fighting diseases, this episode highlights the importance of understanding and treating the microbiome and its potential to improve lives. Tune in to find out more and explore the possibilities of the microbiome with Dr Saman Maleki, and the power of serendipity with Prof Pete Dedon! Transc...
76. Liquid biopsy
August 10, 2023 08:00 - 36 minutes - 33.4 MBIn this episode, we dive into the potential of liquid biopsies as a method to detect deadly diseases. We speak with three experts – Marta Herreros, Rik Bryan, and Doug Ward – to learn more about the non-invasive nature of liquid biopsies and the process of detecting biomarkers within a patient sample. Rik and Doug discuss their GALEAS Bladder test, which can identify key mutations present in 96% of bladder cancer patients. Tune in to learn more about the potential of liquid biopsies and the ...
75. The state of the industry
June 22, 2023 14:23 - 33 minutes - 30.5 MBWhy do China and US have different government regulations? Why can’t we do business above the fray? These are just some of the struggles biopharma executives report impacting their business. Our guests are of the same view – the industry needs fixing. Yingke He, CEO and Co-Founder of Forecyte Bio, explains how China's industrialized experience is limited and in its early stages compared to the US. Listen to this episode to understand the industry tensions and areas showing promise. Tra...
74. Patient-derived organoids
May 30, 2023 14:07 - 23 minutes - 31.7 MBIn this episode of Discovery Matters, we explore the incredible advances in precision medicine enabled by organoid technology. Vicky Marsh Durban and Oksana Sirenko contribute to the conversation, talking about how machine learning and robotics are used to scale up organoid culture and analyse data, as well as the potential of organoids to revolutionise regenerative medicine. Listen to this episode for an insightful and informative deep dive into the potential of organoids for transforming t...
73. War! What is it good for?
May 16, 2023 10:40 - 15 minutes - 21.2 MBWar! What is it good for? In this episode of Discovery Matters, Dr Smith explains how military medicine first shaped state medicine and how wartime creates an opportunity to innovate. From advances in prosthetics, psychology, and cosmetic surgery to the mass production of penicillin during World War II, this episode dives deep into the life-saving innovations brought over the line due to conflicts. Show notes More is Better: English Language Statistics are Biased Toward Addition - Winter ...
72. Cryogenic cold chains and CAR-T
April 24, 2023 13:47 - 14 minutes - 13.8 MBOn the latest episode of Discovery Matters, Dodi and Conor are joined by John Morris, a scientist at the forefront of cryopreservation technology. They discuss the impact of cryopreservation on the development of CAR-T therapies, why freezing cells is essential to these treatments, how tracking the samples ensures quality, and the potential for frozen cells to treat solid tumors in the future. Tune in to find out how cryopreservation has transformed the life sciences and how it could revolut...
72. Cryogenic cold chains and CAR T
April 24, 2023 13:47 - 14 minutes - 13.8 MBJohn Morris, a scientist at the forefront of cryopreservation technology, joins Dodi and Conor. They discuss the impact of cryopreservation on the development of CAR T therapies, why freezing cells is essential to these treatments, how tracking the samples ensures quality, and the potential for frozen cells to treat solid tumors in the future. Tune in to find out how cryopreservation has transformed the life sciences and how it could revolutionize how we treat disease in the future. Show no...
71. Revived therapies (part 2) - Phage therapy
April 14, 2023 14:27 - 20 minutes - 19.3 MBConor and Dodi explore the new and exciting world of bacteriophage therapy. Join them as they speak to Anton Peleg, Professor of Infectious Diseases and Microbiology and the Director of the Department of Infectious Diseases at the Alfred Hospital and Monash University, about this emerging field. Together they discuss how phages, viruses that specifically target bacteria, are being used to fight against antibiotic-resistant superbugs and the challenges of producing them at scale and getting t...
70. Anti-cancer molecules
March 23, 2023 09:00 - 14 minutes - 33.2 MBIn the latest episode of Discovery Matters, Dodi and Conor are joined by Dr. Bradley Moore from the Scripps Institution of Oceanography to discuss his research into the medical and synthetic implications of using marine microbes to fight aggressive cancers such as glioblastoma. By leveraging salinosporamide A, Dr. Moore proposes that these deep-sea organisms could potentially be scaled up for human use and repurposed for medicinal and synthetic purposes. Dive into this episode to hear how th...
69. Never underestimate a cell
March 13, 2023 10:13 - 22 minutes - 21.2 MBWe should not underestimate cells. Conor and Dodi talk with Dr Brett Kagan, who conducted research to understand the brain and test ‘sentient’ brain cells, using the 1970s game, known as ‘Pong’. In another conversation, Professor Petra Levin and Kunaal Joshi explain how they have demonstrated that there is no mythical ‘average’ cell which mimics the stochastic behaviors of any individual cell. At the end of this episode, we hope to have proven that cells are not to be overlooked and still h...
68. CRISPR and molecular aging
February 23, 2023 10:22 - 25 minutes - 58.4 MBWhat do CRISPR and longevity have in common? Not much, except it's all molecular. We spoke to two different CEOs focused on improving human health. We begin with Dr Benjamin Oakes, Co-Founder, President, and CEO of Scribe Therapeutics, who takes us through the discovery, potential, and possible limitations of CRISPR. Then we are joined by fellow visionary Kristen Fortney, the CEO and co-founder of BioAge, a clinical-stage biotechnology company developing therapies that treat disease by tar...
67. Revived therapies (part 1): Psychedelics
February 09, 2023 08:00 - 24 minutes - 56.7 MBPsychedelic treatment is a therapy which is on the rise according to the increasing number of studies on the use of psilocybin, ketamine and MDMA to treat mental health disorders such as PTSD. In this episode, Conor talks to Prof. Eric Vermetten, a psychiatrist who has been working with the military in the Netherlands for the last 25 years, helping Dutch armed forces and the uniformed people in the face of PTSD and psychotraumatology. Show notes For more info on Prof. Eric Vermetten’s work...
66. Getting ÄKTA ready in virtual reality
January 12, 2023 09:25 - 25 minutes - 35.5 MBConor and Dodi try their hand at learning to operate an ÄKTA ready in virtual reality. Their virtual journey takes them to Singapore and Miami, without leaving Sweden, Amersham, and Edinburgh. Join us on a journey into the metaverse. Show notes For more info on using virtual reality for customers: cytiva.com/vr You can view the video version of the episode here, where you can see virtual Dodi and Conor interact with virtual Arron Greig (our expert guide). Transcript Keywords: virtual re...
65. Best of 2022
December 22, 2022 09:00 - 16 minutes - 37 MBMushrooms on Mars, life-saving blood from worms, cell-cultured seafood. It's been a year filled with surprise, serendipity, and everything in between. Conor, Dodi and the podcast team look back on a fascinating year and highlight their favourite interviews and topics of the year. See you in the new year! Show notes More info on Conor’s favorite: What is Quorn mycoprotein? | Quorn More info on Dodi’s favorite: How We Make Chocolate and Coffee From Plant Cell Culture Technology — The Futu...
64. Pain in the body and brain
December 08, 2022 09:40 - 20 minutes - 18.9 MBThis episode focuses on the microbiome and how it is increasingly linked to disease and illness. It seems this is true for understanding the illness of the body and the brain. Dr Amir Minerbi, the Deputy Director of the Institute for Pain Medicine at Rambam Medical Center, talks to us about how the microbiome may hold the secrets of fibromyalgia. This chronic disorder causes widespread pain, fatigue, cognitive dysfunction, and potentially dozens of other symptoms. We are also joined by Prof...
63. Organ on a chip: part 2
November 24, 2022 12:00 - 18 minutes - 42.3 MBToday, we sat down with Christos Michas, R&D scientist and engineer at Curi Bio, and Alice White, professor of mechanical engineering at Boston University. Christos and Alice have taken the organ on a chip to another level with the miniPUMP, a heart on a chip which is the first step in understanding the interaction of therapeutic drugs with the heart. Show notes Christos Michas and Alice White et al. (2022) ‘Engineering a living cardiac pump on a chip using high-precision fabrication’, Sc...
62. Organ on a chip: Part 1
November 10, 2022 09:00 - 15 minutes - 34.5 MBIn this first in a two-part series on organ on a chip technology, we discuss with Jan Turner, formerly part of Safer Medicines Trust, how these organoids can help us move away from the inefficient animal model. Show notes Emulate study on LiverTox - Liver-Chip Publication | Qualifying a human Liver-Chip for predictive toxicology (emulatebio.com) Transcript Keywords: chips, drugs, organ, human, model, cells, technology, testing, animal models, animal testing, microbiome, preclinical testi...
61. Genetic and genomic databases
October 27, 2022 08:00 - 26 minutes - 36.8 MBWe have lots of information at our fingertips, so how do we make sense of it all, especially in human health? Conor and Dodi speak to two experts making sense of this information overload by creating genetic and genomic databases. Dr Artem Babaian, a computational biologist and now Assistant Professor leading The Laboratory for RNA-Based Lifeforms at the University of Toronto, explains how he and his team uncovered 100,000 novel viruses in old genetic data that could help us predict future...
60. The talk on talent
October 13, 2022 08:21 - 32 minutes - 45.3 MBWithin the life sciences industry, there has been a longstanding conversation around one of the industry’s most difficult challenges. That challenge is talent. In more detail, it is that the access to a global talent pool remains difficult. In this longer than usual conversation, Conor and Dodi speak with Darrin Morrissey, CEO of NIBRT, Anne-Cecile Potmans, general manager of Fast Trak and CDMO services at Cytiva, and Nikki Soares, global talent acquisition leader at Cytiva. We discuss how ...
59. Microscopic eco-warriors
September 29, 2022 14:01 - 22 minutes - 50.7 MBPlastic and pollution are two issues that impact our planet. It would be easy to despair but once again biology has come to save us. The Alper Lab at University of Texas at Austin has engineered a plastic-eating enzyme which can shorten plastic degradation from hundreds of years to 48 hours. We speak to Dr Hal Alper, Professor in Chemical Engineering at UT at Austin, who engineered this heroic enzyme. We also speak to Marco Poletto, director and co-founder of EcoLogic studio, which is a de...
58. Wastewater epidemiology: Something in the wastewater
August 25, 2022 16:30 - 19 minutes - 27 MBWastewater-based epidemiology is a relatively new approach to determine the viral make up in any given area. Using chemical analysis of pollutants and biomarkers in raw wastewater, the level of exposure to certain pathogens can be assessed. This technique was used during the pandemic, which has helped realize its potential in public healthcare policy. We speak to Prof. Dominic Frigon, a specialist of biological wastewater resource recovery at McGill University, who used this technique in Qu...
57. Special blood and transplants
June 30, 2022 07:00 - 18 minutes - 24.9 MBThis episode is all about special blood and transplants. We speak to Jon Adkins, co-founder of XenoTherapeutics, who walks us through their use of xenotransplantation for skin grafts and organ transplantation. We are also joined by Dr. Franck Zal, a marine biologist, CSO and CEO of Hemarina, to discuss the lugworm. His discovery, that the lugworms’ blood is compatible with human blood, means it can be used in medical applications for transplants. Join us for this eye-opening and insightful ...
56. Understanding and treating Alzheimer’s
June 16, 2022 07:00 - 23 minutes - 31.7 MBIn this episode, we contemplate the combatting the devastating disease that Alzheimer’s is. According to a recent report by the Alzheimer’s Disease International, an estimated 50 million people are living with dementia due to Alzheimer’s disease. We talk to two experts leading two respective early-stage studies into possible treatments for Alzhemier’s. One study looks at the tackling of tau proteins, another looks at treating aging rather than the disease itself. Join us for this fascinatin...
55. The injustice of disease burden and access to vaccines
May 26, 2022 13:16 - 20 minutes - 28.6 MBThe pandemic has been a global issue, which has benefitted from the coming together of industry, pharma, academia, non-governmental and governmental support. What the pandemic has also brought into sharp focus is the global imbalance access to healthcare and health inequity between the Global North and Global South. For this important conversation, we are joined by Professor Linda-Gail Bekker, Chief Operating Officer of the Desmond Tutu HIV Foundation about the current situation with HIV an...
54. Mycoprotein v. cell-cultured seafood
May 12, 2022 07:00 - 17 minutes - 16 MBWe know meat is problematic for the environment, and seafood has its own issues with overfishing, so do we have to wave goodbye to the foods we love? Well, what if we told you that there are substitutes which you can enjoy without sacrificing taste and texture? We start with mycoprotein, in the form of the well-known meat substitute products of Quorn Foods. Tim Finnigan, Chief Scientific Advisor for Quorn Foods, explains why mycoprotein is such a suitable source of protein, how it is manuf...
53. The future of GMOs
May 11, 2022 14:10 - 20 minutes - 28.8 MBAccording to Jacob Moe-Lange from California Cultured, and Natasha Haveman from the UF Space Plant Lab, genetically modified food is the future. Both discuss the way that food is grown and how that is changing. Jacob takes us through cell-cultured chocolate and the environmental and humanitarian benefits. Natasha forces our gaze upwards to the plant experiments happening in spaceflight conditions, where scientists are learning how plants adapt to new environmental stresses. In this episode,...
52. The magical world of fungi (part 2)
May 11, 2022 14:10 - 15 minutes - 20.9 MBFungi are amazing in so many ways, and after learning that they could be used to build habitat on Mars, we have this bonus episode to go into home these mushrooms can be used on Earth. Chris Maurer, principal architect at redhouse studios, explains that he has been using mushrooms to make building materials in low-resource environments in Namibia. These materials prove even better than concrete. Join Dodi and Conor for this episode on a truly amazing use of biology to solve our problems. T...
51. Women in STEM
May 11, 2022 12:20 - 19 minutes - 26.2 MBMarch is the month of the Woman, and to celebrate International Women’s Day we speak with two agents of change who are passionate about opportunity and diversity within the sciences. Ruchi Sharma, CEO and Founder of Stemnovate Limited, and Sabrina Fleurimé, drug product development scientist and Corporate Partnership Director at BBSTEM, talk to us about what we can all do to become agents of change. Ruchi Sharma is recognized as one of the ones to watch entrepreneurs in the health industry,...
50. Biomimicry in space exploration
February 24, 2022 09:18 - 19 minutes - 27.1 MBSustained life and colonization in space are closer than ever, and biology holds the key. Biomimetic processes have applications for water filtration and for building homes on Mars. Jörg Vogel, VP of Open Innovation at Aquaporin, discusses how their Aquaporin Inside® Membrane Technology will help filter condensate and urine to make drinking water for astronauts. We are also joined by Chris Maurer, an architect and founder of redhouse studios in Cleveland, Ohio. Chris is working on a project...
49. Discovery Makers: Mustapha Bittaye
January 27, 2022 10:19 - 16 minutes - 15.2 MBMeet Discovery Maker Mustapha Bittaye, now a senior scientist working on diagnostic assay development at Medicines Discovery Catapult, who previously worked as a postdoctoral researcher at the Jenner Institute helping create the Oxford/AstraZeneca vaccine. Born in The Gambia, a scholarship took Mustapha to the UK to study Microbial Proteomics, and from then onwards he has made truly amazing contributions to human health globally. Conor and Dodi examine Mustapha’s story, truly brilliant mind...
48. Discovery Makers: Sebastian Falk
January 13, 2022 15:09 - 22 minutes - 30.3 MBWhat better way to start off 2022 than with a return to our Discovery Makers series. We celebrate discovery by talking to the scientists changing the world one day at a time. This time we are joined by Sebastian Falk. What drives a scientist? Well, according to Sebastian Falk, it is curiosity that drives him. Sebastian is a structural biologist who is leading a research group at the Max Perutz Labs investigating the structure and function of proteins, and how they work in RNA metabolism. In...
47. Best of 2021
December 23, 2021 09:15 - 16 minutes - 22 MBAs 2022 rolls around the corner, we look back on the amazing topics we covered in 2021. Conor and Dodi were set an assignment to choose their favorite episode of the year, but as this was such a jam-packed year it made it very hard for them to complete their assignment. But as in all things, they delivered. From fungi forays to an eye-opening conversation with Dr Joan Reede, President of the BSCP, Dodi and Conor discuss the best moments of the year, with a little input from the production t...
46. The pulse on the industry - BioPlan and the Biopharma Resilience Index
December 09, 2021 10:59 - 18 minutes - 24.8 MBFor this episode of Discovery Matters we are focusing on industry surveys and what they can tell us. This includes BioPlan and the Biopharma Resilience Index. Both huge reports providing insight into both the issues and opportunities facing the industry today. Firman Ghouze, Cytiva’s Marketing Director in APAC, explains how the Biopharma Resilience Index came about, the industry issues it uncovers and potential solutions. We are also joined by Eric Langer, from BioPlan Associates, to discus...
46. The pulse of the industry - BioPlan and the Biopharma Resilience Index
December 09, 2021 10:59 - 18 minutes - 24.8 MBFor this episode of Discovery Matters we are focusing on industry surveys and what they can tell us. This includes BioPlan and the Biopharma Resilience Index. Both huge reports providing insight into both the issues and opportunities facing the industry today. Firman Ghouze, Cytiva’s Marketing Director in APAC, explains how the Biopharma Resilience Index came about, the industry issues it uncovers and potential solutions. We are also joined by Eric Langer, from BioPlan Associates, to discus...
45. Detecting sepsis: the role of single-cell
November 11, 2021 10:28 - 17 minutes - 24 MBSingle-cell sequencing is a technology that is giving us new genomic capabilities. Dr. Luciano Martelotto joins us to explain how single-cell sequencing allows scientists to understand cells as building blocks, much like LEGO™, which form part of a much bigger structure such as an organ, a tissue, a disease, and so forth. Dr. James McLaren utilizes this technology to look at septicemia; in his work he is using single-cell analysis to better understand sepsis and to develop a rapid diagnostic...
44. Insects as biotech engines
October 28, 2021 09:06 - 20 minutes - 27.5 MBWe’ve talked about slime, seaweed, mushrooms, and now creepy crawlies. Insects are important biotech engines for medicines and meals. Algenex are using insect pupa to produce recombinant proteins that can be used for vaccines, which also has the potential to replace less sustainable raw materials. Insects are also excellent food sources, not just for bush tucker trials, but Dr. Daylan Tzompa-Sosa explains that insect lipids can make doughnuts, croissants, oils, and hummus! Join Dodi, Conor ...
43. Crossing the finishing line in biotech
October 14, 2021 13:50 - 15 minutes - 14.6 MBWe talk a lot about beginnings on Discovery Matters, but what about actually getting biologic drugs to people? Once the biologic is produced, aseptic filling and hybrid glass and plastic vials help to protect the biologic drug and the patient. Join Dodi, Conor and their guests, Chris Weikart the Chief Scientist at SiO2 Material Science, and Ross Gold one of the founders of Cytiva's aseptic filling business, in the latest episode of Discovery Matters, talking about the end of the workflow. ...
42. mRNA - the talk of the town
September 16, 2021 11:26 - 18 minutes - 24.7 MBWho (in the scientific community) would have guessed that mRNA would be such a popular word in everyone's vocabulary one day? Well, as Conor puts it, "all the research by the people on the edges of the scientific community for the past 20 years are really paying dividends." Join Dodi, Conor, and their guests, Clive Glover the General Manager of Gene Therapy at Pall and James Taylor General Manager in Vancouver for Precision NanoSystems, in the latest episode of Discovery Matters, talking ab...
41. Seaweed, Agar and Algae
September 02, 2021 17:15 - 21 minutes - 30 MBIn this episode of Discovery Matters, enter into the world of slime: seaweed, agar and algae. Algae gave us the atmosphere that we have today and is still coming to our aid against climate change. Executive Director of the Climate Change Cluster at the University of Technology in Sydney, Photobiologist Peter Ralph, who once called himself Dr. Death, explains how algae has given him newfound hope to fight climate change. Join Conor and Dodi for this fascinating episode! Transcript Keywords...
40. 'Joan's Ideal': One real story - and advice - on inclusion in the sciences
August 19, 2021 14:40 - 17 minutes - 23.7 MBThe BSCP is working towards greater diversity and opportunities for people of colour and disadvantaged individuals within the biomedical and life sciences. Join Dodi and Conor and their guest, Dr Joan Reede, for this important episode where we learn what more can be done by ourselves and the industry as a whole to further diversity and inclusion. Transcript Keywords: students, color, people, organisations, doctors, opportunities, privilege, pandemic, biomedical science, diversity, represe...